Home
About Us
Information & Guidelines
Article Processing Charges
Open Access Policy
Terms and Conditions
Privacy Policy
Information For Authors
Information Editorial Board
Contact Us
FAQ
Paper Submission Guideline
Register
Login
Submit Now
Vol - 25, Issue - 4
Full-Text PDF
About the Journal
Download
[This article belongs to Volume - 25, Issue - 4]
International Medical Journal
Journal ID
:
IMJ-31-03-2020-379
Total View
:
170
Title
:
Perspective Why Children survive from Corona Complications, COVID-19 and MERS
Abstract
: Adults and elderly patients suffering from RVI including that of corona and influenza viruses’ outbreaks, developed severe complications caused by a bacterial co-infection leading to pneumonia, resulting in man death. Some people are vulnerable to develop complications. WHO states that bacterial pneumonia post-RVI elevated mortality up to 38%. However, these complications were not the case in children. Statistical studies showed that pneumoniae was mainly caused by the bacterium S. pneumoniae, that can be detected more in children than adults. In contrast, investigation of infected patients illustrated that children showed no clinical complications post-RVI. Interestingly, in the first two years after birth, children receive 4 doses of PCV13 as declared by Centers for Disease Control and Prevention (CDC). Hence, based on available global data, this perspective suggests that the PCV could ease in protecting victims of RVI, not only with COVID-19, but also with other future emerging human respiratory viruses
Download Info
×
Paper Access Key
Access Key
Submit
No Access Key (
Request for Download
)
Name
Email
Country
Send Request
Our Certificates
Guidelines
Information For Authors
Information Editorial Board
FAQ
Further Information
Article Processing Charges
Open Access Policy
Terms and Conditions
Privacy Policy
//